To determine whether loss of TSC2 sensitizes cells to the oncogenic effects of UII, we used TSC2-deficient Eker rat uterine carcinoma (ELT3) cells stably transfected with empty vector (V3) or a plasmid for expression of TSC2 (T3) as previously described [24]. This evidence concerns the gene TSC2 and uterine carcinoma.